Revascularization in stable coronary artery disease Review article
Article Sidebar
Published:
Jun 30, 2017
Keywords:
revascularization, coronary artery disease
Main Article Content
Abstract
Revascularization in stable coronary artery disease in comparison to medical treatment reduces symptoms and in many cases also improve prognosis. Benefits of the revascularization depend on the area of ischemia. The method of revascularization (CABG vs PCI) is chosen based on extensity of atheroma plaques, anatomy of the vessels, periprocedural risk and preferences of well informed patient.
Article Details
How to Cite
Wrzosek , K. (2017). Revascularization in stable coronary artery disease. Medycyna Faktow (J EBM), 10(2(35), 168-172. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2160
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Windecker S., Kolh P., Alfonso F. et al.: Wytyczne ESC/EACTS dotyczące rewaskularyzacji mięśnia sercowego w 2014 roku. Kardiol. Pol. 2014; 72(12): 1253-1379.
2. Serruys P.W., Morice M.C., Kappetein A.P. et al.: SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009; 360: 961-972.
3. Head S.J., Davierwala P.M., Serruys P.W. et al.: Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur. Heart. J. Published online 21 May 2014 [doi: 10.1093/eurheartj/ehu213].
4. Bangalore S., Pursnani S., Kumar S., Bagos P.G.: Percutaneous coronary intervention vs. optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease. Circulation 2013; 127: 769-781.
5. Windecker S., Stortecky S., Stefanini G.G. et al.: Revascularisation vs. Medical Treatment in Patients With Stable Coronary Artery Disease: A Network Meta-Analysis. BMJ 2014; 348: g3859.
6. Morice M.C., Serruys P.W., Kappetein A.P. et al.: Five-Year Outcomes in Patients with Left Main Disease Treated with Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the SYNTAX Trial. Circulation 2014; 129: 2388-2394.
2. Serruys P.W., Morice M.C., Kappetein A.P. et al.: SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009; 360: 961-972.
3. Head S.J., Davierwala P.M., Serruys P.W. et al.: Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur. Heart. J. Published online 21 May 2014 [doi: 10.1093/eurheartj/ehu213].
4. Bangalore S., Pursnani S., Kumar S., Bagos P.G.: Percutaneous coronary intervention vs. optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease. Circulation 2013; 127: 769-781.
5. Windecker S., Stortecky S., Stefanini G.G. et al.: Revascularisation vs. Medical Treatment in Patients With Stable Coronary Artery Disease: A Network Meta-Analysis. BMJ 2014; 348: g3859.
6. Morice M.C., Serruys P.W., Kappetein A.P. et al.: Five-Year Outcomes in Patients with Left Main Disease Treated with Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the SYNTAX Trial. Circulation 2014; 129: 2388-2394.